
Analyst Insights
BioNTech SE ADR (BNTX) with a beta value of 1.40 appears to be a promising investment opportunity.
BioNTech SE ADR (NASDAQ: BNTX) kicked off on Monday, down -5.24% from the previous trading day, before settling in for the closing price of $110.88.